Jorge Mestre-Ferrandiz - OHE

We found for

The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics

Read more

#image_title

Dementia: The R&D Landscape

Read more

Multi-indication Pricing: Pros, Cons and Applicability to the UK

Read more

The Expanding Value Footprint of Oncology Treatments

Read more

The Current Drug Development Paradigm: Responding to US and European Demands for Evidence of Comparative Effectiveness and Relative Effectiveness

Read more

What is the Role of HTA for Biosimilars?

Read more

Projecting Expenditure on Medicines in the NHS: Second Edition

Read more

Projecting Expenditure on Medicines in the NHS

Read more

The R&D Cost of a New Medicine

Read more

International Comparisons of Medicines Prices: 2011 Indices

Read more

The Many Faces of Innovation

Read more

Assessment of the Impact of Orphan Medicinal Products on the European Economy and Society

Read more

Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe

Read more

Health Policy and Regulation

Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries

Read more

Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending

Read more

The Market for Biosimilars: Evolution and Policy Options

Read more